Generation, characterization and preclinical studies of a human anti-L1CAM monoclonal antibody that cross-reacts with rodent L1CAM

References

• Haspel J, Grumet M. The L1CAM extracellular region: a multi-domain protein with modular and cooperative binding modes. Front Biosci 2003; 8:s1210-25; PMID:12957823; http://dx.doi.org/10.2741/1108
   PubMedGoogle Scholar
• Rathjen FG, Schachner M. Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion. EMBO J 1984; 3:1-10; PMID:6368220
   PubMed Web of Science ®Google Scholar
• Pancook JD, Reisfeld RA, Varki N, Vitiello A, Fox RI, Montgomery AM. Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin. J Immunol 1997; 158:4413-21; PMID:9127006
   PubMed Web of Science ®Google Scholar
• Debiec H, Christensen EI, Ronco PM. The cell adhesion molecule L1 is developmentally regulated in the renal epithelium and is involved in kidney branching morphogenesis. J Cell Biol 1998; 143:2067-79; PMID:9864376; http://dx.doi.org/10.1083/jcb.143.7.2067
   PubMed Web of Science ®Google Scholar
• Thor G, Probstmeier R, Schachner M. Characterization of the cell adhesion molecules L1, N-CAM and J1 in the mouse intestine. EMBO J 1987; 6:2581-6; PMID:3315649
   PubMed Web of Science ®Google Scholar
• Raveh S, Gavert N, Ben-Ze'ev A. L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett 2009; 282:137-45; PMID:19144458; http://dx.doi.org/10.1016/j.canlet.2008.12.021
   PubMed Web of Science ®Google Scholar
• Kiefel H, Bondong S, Erbe-Hoffmann N, Hazin J, Riedle S, Wolf J, Pfeifer M, Arlt A, Schäfer H, Müerköster SS, et al. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression. Oncogene 2010; 29:4766-78; PMID:20543863; http://dx.doi.org/10.1038/onc.2010.230
   PubMed Web of Science ®Google Scholar
• Kiefel H, Bondong S, Pfeifer M, Schirmer U, Erbe-Hoffmann N, Schäfer H, Sebens S, Altevogt P. EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation. Carcinogenesis 2012; 33:1919-29; PMID:22764136; http://dx.doi.org/10.1093/carcin/bgs220
   PubMed Web of Science ®Google Scholar
• Hall H, Walsh FS, Doherty P. Review: a role for the FGF receptor in the axonal growth response stimulated by cell adhesion molecules? Cell Adhes Commun 1996; 3:441-50; PMID:8807188; http://dx.doi.org/10.3109/15419069609081021
   PubMed Web of Science ®Google Scholar
• Donier E, Gomez-Sanchez JA, Grijota-Martinez C, Lakoma J, Baars S, Garcia-Alonso L, Cabedo H. L1CAM binds ErbB receptors through Ig-like domains coupling cell adhesion and neuregulin signalling. PLoS One 2012; 7:e40674; PMID:22815787; http://dx.doi.org/10.1371/journal.pone.0040674
   PubMedGoogle Scholar
• Gouveia RM, Gomes CM, Sousa M, Alves PM, Costa J. Kinetic analysis of L1 homophilic interaction: role of the first four immunoglobulin domains and implications on binding mechanism. J Biol Chem 2008; 283:28038-47; PMID:18701456; http://dx.doi.org/10.1074/jbc.M804991200
   PubMed Web of Science ®Google Scholar
• Haspel J, Friedlander DR, Ivgy-May N, Chickramane S, Roonprapunt C, Chen S, Schachner M, Grumet M. Critical and optimal Ig domains for promotion of neurite outgrowth by L1/Ng-CAM. J Neurobiol 2000; 42:287-302; PMID:10645969; http://dx.doi.org/10.1002/(SICI)1097-4695(20000215)42:3%3c287::AID-NEU1%3e3.0.CO;2-X
   PubMedGoogle Scholar
• Yip PM, Zhao X, Montgomery AM, Siu CH. The Arg-Gly-Asp motif in the cell adhesion molecule L1 promotes neurite outgrowth via interaction with the alphavbeta3 integrin. Mol Biol Cell 1998; 9:277-90; PMID:9450954; http://dx.doi.org/10.1091/mbc.9.2.277
   PubMed Web of Science ®Google Scholar
• Kulahin N, Li S, Hinsby A, Kiselyov V, Berezin V, Bock E. Fibronectin type III (FN3) modules of the neuronal cell adhesion molecule L1 interact directly with the fibroblast growth factor (FGF) receptor. Mol Cell Neurosci 2008; 37:528-36; PMID:18222703; http://dx.doi.org/10.1016/j.mcn.2007.12.001
   PubMed Web of Science ®Google Scholar
• Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM. Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 2004; 279:28880-8; PMID:15128735; http://dx.doi.org/10.1074/jbc.M404075200
   PubMed Web of Science ®Google Scholar
• Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze'ev A. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 2005; 168:633-42; PMID:15716380; http://dx.doi.org/10.1083/jcb.200408051
   PubMed Web of Science ®Google Scholar
• Zecchini S, Bianchi M, Colombo N, Fasani R, Goisis G, Casadio C, Viale G, Liu J, Herlyn M, Godwin AK, et al. The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res 2008; 68:1110-8; PMID:18281486; http://dx.doi.org/10.1158/0008-5472.CAN-07-2897
   PubMed Web of Science ®Google Scholar
• Min JK, Kim JM, Li S, Lee JW, Yoon H, Ryu CJ, Jeon SH, Lee JH, Kim JY, Yoon HK, et al. L1 cell adhesion molecule is a novel therapeutic target in intrahepatic cholangiocarcinoma. Clin Cancer Res 2010; 16:3571-80; PMID:20501614; http://dx.doi.org/10.1158/1078-0432.CCR-09-3075
   PubMed Web of Science ®Google Scholar
• Jung J, Son YS, Park H, Jeon SK, Lee JW, Choi SY, Kim JM, Kwon YG, Hong HJ, Min JK. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo. Oncol Rep 2011; 25:945-52; PMID:21318226; http://dx.doi.org/10.3892/or.2011.1181
   PubMed Web of Science ®Google Scholar
• Sebens Muerkoster S, Werbing V, Sipos B, Debus MA, Witt M, Grossmann M, Leisner D, Kötteritzsch J, Kappes H, Klöppel G, et al. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 2007; 26:2759-68; PMID:17086212; http://dx.doi.org/10.1038/sj.onc.1210076
   PubMed Web of Science ®Google Scholar
• Ben Q, An W, Fei J, Xu M, Li G, Li Z, Yuan Y. Downregulation of L1CAM inhibits proliferation, invasion and arrests cell cycle progression in pancreatic cancer cells. Exp Ther Med 2014; 7:785-90; PMID:24660028
   PubMed Web of Science ®Google Scholar
• Yoon H, Min JK, Lee DG, Kim DG, Koh SS, Hong HJ. L1 cell adhesion molecule and epidermal growth factor receptor activation confer cisplatin resistance in intrahepatic cholangiocarcinoma cells. Cancer Lett 2012; 316:70-6; PMID:22088438; http://dx.doi.org/10.1016/j.canlet.2011.10.024
   PubMed Web of Science ®Google Scholar
• Magrini E, Villa A, Angiolini F, Doni A, Mazzarol G, Rudini N, Maddaluno L, Komuta M, Topal B, Prenen H, et al. Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization. J Clin Invest 2014; 124:4335-50; PMID:25157817; http://dx.doi.org/10.1172/JCI70683
   PubMed Web of Science ®Google Scholar
• Grage-Griebenow E, Jerg E, Gorys A, Wicklein D, Wesch D, Freitag-Wolf S, Goebel L, Vogel I, Becker T, Ebsen M, et al. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression. Mol Oncol 2014; 8:982-97; PMID:24746181; http://dx.doi.org/10.1016/j.molonc.2014.03.001
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344:783-92; PMID:11248153; http://dx.doi.org/10.1056/NEJM200103153441101
   PubMed Web of Science ®Google Scholar
• Smith IE. Trastuzumab for early breast cancer. Lancet 2006; 367:107; PMID:16413866; http://dx.doi.org/10.1016/S0140-6736(06)67951-8
   PubMed Web of Science ®Google Scholar
• Baselga J, Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer 2009; 9:463-75; PMID:19536107; http://dx.doi.org/10.1038/nrc2656
   PubMed Web of Science ®Google Scholar
• Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004; 351:337-45; PMID:15269313; http://dx.doi.org/10.1056/NEJMoa033025
   PubMed Web of Science ®Google Scholar
• Arlt MJ, Novak-Hofer I, Gast D, Gschwend V, Moldenhauer G, Grunberg J, Honer M, Schubiger PA, Altevogt P, Krüger A. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 2006; 66:936-43; PMID:16424028; http://dx.doi.org/10.1158/0008-5472.CAN-05-1818
   PubMed Web of Science ®Google Scholar
• Wolterink S, Moldenhauer G, Fogel M, Kiefel H, Pfeifer M, Luttgau S, Gouveia R, Costa J, Endell J, Moebius U, et al. Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma. Cancer Res 2010; 70:2504-15; PMID:20215505; http://dx.doi.org/10.1158/0008-5472.CAN-09-3730
   PubMed Web of Science ®Google Scholar
• Lee ES, Jeong MS, Singh R, Jung J, Yoon H, Min JK, Kim KH, Hong HJ. A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model. Exp Mol Med 2012; 44:293-302; PMID:22248567; http://dx.doi.org/10.3858/emm.2012.44.4.027
   PubMed Web of Science ®Google Scholar
• McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348:552-4; PMID:2247164; http://dx.doi.org/10.1038/348552a0
   PubMed Web of Science ®Google Scholar
• Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. Making antibodies by phage display technology. Annu Rev Immunol 1994; 12:433-55; PMID:8011287; http://dx.doi.org/10.1146/annurev.iy.12.040194.002245
   PubMed Web of Science ®Google Scholar
• Boder ET, Wittrup KD. Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 1997; 15:553-7; PMID:9181578; http://dx.doi.org/10.1038/nbt0697-553
   PubMed Web of Science ®Google Scholar
• Zhou H, Zhang YL, Lu G, Ji H, Rodi CP. Recombinant antibody libraries and selection technologies. N Biotechnol 2011; 28:448-52; PMID:21477669; http://dx.doi.org/10.1016/j.nbt.2011.03.013
   PubMed Web of Science ®Google Scholar
• Bradbury AR, Sidhu S, Dubel S, McCafferty J. Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol 2011; 29:245-54; PMID:21390033; http://dx.doi.org/10.1038/nbt.1791
   PubMed Web of Science ®Google Scholar
• Chao G, Lau WL, Hackel BJ, Sazinsky SL, Lippow SM, Wittrup KD. Isolating and engineering human antibodies using yeast surface display. Nat Protoc 2006; 1:755-68; PMID:17406305; http://dx.doi.org/10.1038/nprot.2006.94
   PubMed Web of Science ®Google Scholar
• Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366:1303-14; PMID:16214602; http://dx.doi.org/10.1016/S0140-6736(05)67530-7
   PubMed Web of Science ®Google Scholar
• Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362:1273-81; PMID:20375404; http://dx.doi.org/10.1056/NEJMoa0908721
   PubMed Web of Science ®Google Scholar
• Rizvi S, Borad MJ, Patel T, Gores GJ. Cholangiocarcinoma: molecular pathways and therapeutic opportunities. Semin Liver Dis 2014; 34:456-64; PMID:25369307; http://dx.doi.org/10.1055/s-0034-1394144
   PubMed Web of Science ®Google Scholar
• Li S, Jo YS, Lee JH, Min JK, Lee ES, Park T, Kim JM, Hong HJ. L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma. Clin Cancer Res 2009; 15:7345-51; PMID:19920102; http://dx.doi.org/10.1158/1078-0432.CCR-09-0959
   PubMed Web of Science ®Google Scholar
• Choi SY, Jo YS, Huang SM, Liang ZL, Min JK, Hong HJ, Kim JM. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma. Hum Pathol 2011; 42:1476-83; PMID:21496863; http://dx.doi.org/10.1016/j.humpath.2011.01.003
   PubMed Web of Science ®Google Scholar
• Wei CH, Lee ES, Jeon JY, Heo YS, Kim SJ, Jeon YH, Kim KH, Hong HJ, Ryu SE. Structural mechanism of the antigen recognition by the L1 cell adhesion molecule antibody A10-A3. FEBS Lett 2011; 585:153-8; PMID:21094640; http://dx.doi.org/10.1016/j.febslet.2010.11.028
   PubMed Web of Science ®Google Scholar
• Weidle UH, Eggle D, Klostermann S. L1-CAM as a target for treatment of cancer with monoclonal antibodies. Anticancer Res 2009; 29:4919-31; PMID:20044598
   PubMed Web of Science ®Google Scholar
• Mechtersheimer S, Gutwein P, Agmon-Levin N, Stoeck A, Oleszewski M, Riedle S, Postina R, Fahrenholz F, Fogel M, Lemmon V, et al. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 2001; 155:661-73; PMID:11706054; http://dx.doi.org/10.1083/jcb.200101099
   PubMed Web of Science ®Google Scholar
• Schafer H, Dieckmann C, Korniienko O, Moldenhauer G, Kiefel H, Salnikov A, Krüger A, Altevogt P, Sebens S. Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma. Cancer Lett 2012; 319:66-82; PMID:22210381; http://dx.doi.org/10.1016/j.canlet.2011.12.035
   PubMed Web of Science ®Google Scholar
• Kiefel H, Bondong S, Hazin J, Ridinger J, Schirmer U, Riedle S, Altevogt P. L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr 2012; 6:374-84; PMID:22796939; http://dx.doi.org/10.4161/cam.20832
   PubMed Web of Science ®Google Scholar
• Donato R, Miljan EA, Hines SJ, Aouabdi S, Pollock K, Patel S, Edwards FA, Sinden JD. Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neurosci 2007; 8:36; PMID:17531091; http://dx.doi.org/10.1186/1471-2202-8-36
   PubMed Web of Science ®Google Scholar
• Urlaub G, Kas E, Carothers AM, Chasin LA. Deletion of the diploid dihydrofolate reductase locus from cultured mammalian cells. Cell 1983; 33:405-12; PMID:6305508; http://dx.doi.org/10.1016/0092-8674(83)90422-1
   PubMed Web of Science ®Google Scholar
• Jung E, Lee J, Hong HJ, Park I, Lee Y. RNA recognition by a human antibody against brain cytoplasmic 200 RNA. RNA 2014; 20:805-14; PMID:24759090; http://dx.doi.org/10.1261/rna.040899.113
   PubMed Web of Science ®Google Scholar
• Oh MS, Kim KS, Jang YK, Maeng CY, Min SH, Jang MH, Yoon SO, Kim JH, Hong HJ. A new epitope tag from hepatitis B virus preS1 for immunodetection, localization and affinity purification of recombinant proteins. J Immunol Methods 2003; 283:77-89; PMID:14659901; http://dx.doi.org/10.1016/j.jim.2003.08.010
   PubMed Web of Science ®Google Scholar
• Coomber DW. Panning of antibody phage-display libraries. Standard protocols. Methods Mol Biol 2002; 178:133-45; PMID:11968482
   PubMedGoogle Scholar
• Yoon SO, Lee TS, Kim SJ, Jang MH, Kang YJ, Park JH, Kim KS, Lee HS, Ryu CJ, Gonzales NR, et al. Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody. J Biol Chem 2006; 281:6985-92; PMID:16407221; http://dx.doi.org/10.1074/jbc.M511165200
   PubMed Web of Science ®Google Scholar
• Lee CV, Liang WC, Dennis MS, Eigenbrot C, Sidhu SS, Fuh G. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J Mol Biol 2004; 340:1073-93; PMID:15236968; http://dx.doi.org/10.1016/j.jmb.2004.05.051
   PubMed Web of Science ®Google Scholar